Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
(2016).
(2015).
(2014).
(2013).
Feasibility and effectiveness of inhaled carboplatin in NSCLC patients..
Invest New Drugs. 30(4), 1628-40.
(2012). Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients..
Lung Cancer. 76(1), 84-8.
(2012). Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature..
Eur J Gynaecol Oncol. 33(3), 312-5.
(2012). Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study..
Clin Lung Cancer. 11(1), 30-5.
(2010). Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group..
Clin Breast Cancer. 10(3), 230-7.
(2010). Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study..
Anticancer Drugs. 21(8), 785-9.
(2010).
(2010). A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer..
Cancer Chemother Pharmacol. 65(6), 1009-21.
(2010). Carboplatin and paclitaxel in metastatic or recurrent cervical cancer..
Int J Gynecol Cancer. 19(4), 777-81.
(2009). Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial..
Ann Oncol. 20(2), 278-85.
(2009). Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients..
Gynecol Oncol. 115(1), 97-101.
(2009). A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study..
Breast Cancer Res Treat. 115(1), 87-99.
(2009). Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer..
Lung Cancer. 66(2), 226-30.
(2009).